Design of a novel class of protein-based magnetic resonance imaging contrast agents for the molecular imaging of cancer biomarkers.

Wiley Interdiscip Rev Nanomed Nanobiotechnol 2013 Mar-Apr;5(2):163-79. Epub 2013 Jan 17.

Departments of Chemistry and Biology, Center for Diagnostics & Therapeutics, Georgia State University, Atlanta, GA, USA.

Magnetic resonance imaging (MRI) of disease biomarkers, especially cancer biomarkers, could potentially improve our understanding of the disease and drug activity during preclinical and clinical drug treatment and patient stratification. MRI contrast agents with high relaxivity and targeting capability to tumor biomarkers are highly required. Extensive work has been done to develop MRI contrast agents. However, only a few limited literatures report that protein residues can function as ligands to bind Gd(3+) with high binding affinity, selectivity, and relaxivity. In this paper, we focus on reporting our current progress on designing a novel class of protein-based Gd(3+) MRI contrast agents (ProCAs) equipped with several desirable capabilities for in vivo application of MRI of tumor biomarkers. We will first discuss our strategy for improving the relaxivity by a novel protein-based design. We then discuss the effect of increased relaxivity of ProCAs on improving the detection limits for MRI contrast agent, especially for in vivo application. We will further report our efforts to improve in vivo imaging capability and our achievement in molecular imaging of cancer biomarkers with potential preclinical and clinical applications.

Download full-text PDF

Source
http://dx.doi.org/10.1002/wnan.1205DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4011496PMC
August 2013
14 Reads

Publication Analysis

Top Keywords

mri contrast
16
contrast agents
16
cancer biomarkers
12
magnetic resonance
8
imaging cancer
8
molecular imaging
8
resonance imaging
8
tumor biomarkers
8
preclinical clinical
8
vivo application
8
novel class
8
class protein-based
8
mri
6
biomarkers
6
imaging
5
contrast
5
agents procas
4
report protein
4
progress designing
4
gd3+ mri
4

References

(Supplied by CrossRef)
Relaxivity of MRI Contrast Agents. Contrast Agents I
Tóth et al.
Topics in Current Chemistry 2002
Imaging in the era of molecular oncology
Weissleder et al.
Nature 2008
Targeted magnetic resonance imaging contrast agents
Caruthers et al.
Methods Mol Med 2006

Similar Publications